Abstract:Background:Exenatide (exendin-4) is an incretin mimetic currently marketed as an antidiabetic agent for patients with type 2 diabetes. In preclinical models, a reduction in body weight has also been shown in low-fat-fed, leptin receptor-deficient rodents.Objective:To more closely model the polygenic and environmental state of human obesity, we characterized the effect of exenatide on food intake and body weight in high-fat-fed, normal (those with an intact leptin signaling system) rodents. As glucagon-like peptide-1 receptor agonism has been found to elicit behaviors associated with visceral illness in rodents, we also examined the effect of peripheral exenatide on kaolin consumption and locomotor activity.Methods and results:High-fat-fed C57BL/6 mice and Sprague–Dawley rats were treated with exenatide (3, 10 and 30 μg/kg/day) for 4 weeks via subcutaneously implanted osmotic pumps. Food intake and body weight were assessed weekly. At 4 weeks, body composition and plasma metabolic profiles were measured. Kaolin consumption and locomotor activity were measured in fasted Sprague–Dawley rats following a single intraperitoneal injection of exenatide (0.1–10 μg/kg). Exenatide treatment in mice and rats dose-dependently decreased food intake and body weight; significant reductions in body weight gain were observed throughout treatment at 10 and 30 μg/kg/day (P<0.05). Decreased body weight gain was associated with a significant decrease in fat mass (P<0.05) with sparing of lean tissue. Plasma cholesterol, triglycerides and insulin were also significantly reduced (P<0.05). Exenatide at 10 μg/kg significantly reduced food intake (P<0.05) but failed to induce kaolin intake. In general, locomotor activity was reduced at doses of exenatide that decreased food intake, although a slightly higher dose was required to produce significant changes in activity.Conclusion:Systemic exenatide reduces body weight gain in normal, high-fat-fed rodents, a model that parallels human genetic variation and food consumption patterns, and may play a role in metabolic pathways mediating food intake.

Eexperimental study of exendin-4 for weight reduction in obese rats

Long-term Effect of Exendin-4 on Weight Reduction of Normal Rats

Exendin-4 Improves Fat Metabolism of Brown Adipose Tissue in High-Fat Diet-Induced Obese C57BL/6J Mice

Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures

Effect of Exendin-4 on Lipid Deposition in Skeletal Muscle of Diet-Induced Obese Mice and Its Underlying Mechanism

Exendin-4 Improves Thermogenic Capacity by Regulating Fat Metabolism on Brown Adipose Tissue in Mice with Diet-Induced Obesity

Effects of Exendin-4 on Glucose and Lipid Metabolism in Diabetic Rats

Effects of Exenatide on Autophagy and Occurrence of Brown Adipocytes for White Adipose Tissue in Obese Rats

[The Preliminary Investigation of GLP-1 Receptor Agonist on Liver Steatosis in Obese Mice].

Effect of Exendin-4 on the Glucose Tolerance and Serum Glucose Level in Normal Animals

The Anorexic Effect of Ex4/Fc Through Glp-1 Receptor Activation in High-Fat Diet Fed Mice

Effect of GLP-1 receptor agonist on lipolysis in adipose tissue of obese mice and its underlying mechanism

Experimental Study on the Obesity Rat Model Induced by Vitamin D

Effects of Glucagon-Like Peptide-1 Analogue (Exendin-4) on the Function of Β-Cell and Insulin Resistance in OLETF Diabetic Rats

Effects of Exendin-4 on Glucose Metabolism and Pdx-1 Mrna Expression in OLETF Rat

Exendin-4 improves long-term potentiation and neuronal dendritic growth in vivo and in vitro obesity condition

Exendin-4 Directly Improves Endothelial Dysfunction in Isolated Aortas from Obese Rats Through the Camp or Ampk-Enos Pathways

Alteration of sweet taste in high-fat diet induced obese rats after 4 weeks treatment with exenatide.

Effects of Exenatide on Lipid Metabolism of Adipose Tissue in Diabetic Rats

Glucagon-like Peptide-1 Improves Fatty Liver and Enhances Thermogenesis in Brown Adipose Tissue via Inhibiting BMP4-Related Signaling Pathway in High-Fat-Diet-Induced Obese Mice

Potential Role Of Hypothalamic And Plasma Ghrelin In The Feeding Behavior Of Obese Type 2 Diabetic Rats With Intraventricular Glucagon-Like Peptide-1 Receptor Agonist Intervention